After finishing at $82.09 in the prior trading day, Carters Inc (NYSE: CRI) closed at $83.14, up 1.28%. In other words, the price has increased by $+1.05 from its previous closing price. On the day, 687706 shares were traded.
Ratios:
Our goal is to gain a better understanding of CRI by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.64 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.46. For the most recent quarter (mrq), Quick Ratio is recorded 1.10 and its Current Ratio is at 2.15. In the meantime, Its Debt-to-Equity ratio is 1.28 whereas as Long-Term Debt/Eq ratio is at 1.12.
On January 26, 2023, Wedbush Downgraded its rating to Neutral which previously was Outperform but kept the price unchanged to $78.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 13 ’24 when Jenkins Jeff sold 1,060 shares for $86.00 per share. The transaction valued at 91,160 led to the insider holds 35,173 shares of the business.
Hipp Mark sold 1,875 shares of CRI for $153,261 on Mar 06 ’24. The Director now owns 10,216 shares after completing the transaction at $81.74 per share. On Dec 14 ’23, another insider, CASEY MICHAEL DENNIS, who serves as the Chairman and CEO of the company, sold 89,139 shares for $75.00 each. As a result, the insider received 6,685,425 and left with 390,731 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRI now has a Market Capitalization of 3.03B and an Enterprise Value of 3.76B. As of this moment, Carters’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.26, and their Forward P/E ratio for the next fiscal year is 12.47. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.03 while its Price-to-Book (P/B) ratio in mrq is 3.60. Its current Enterprise Value per Revenue stands at 1.28 whereas that against EBITDA is 9.40.
Stock Price History:
The Beta on a monthly basis for CRI is 1.29, which has changed by 19.15% over the last 52 weeks, in comparison to a change of 29.57% over the same period for the S&P500. Over the past 52 weeks, CRI has reached a high of $88.03, while it has fallen to a 52-week low of $60.65. The 50-Day Moving Average of the stock is 80.36, while the 200-Day Moving Average is calculated to be 72.98.
Shares Statistics:
The stock has traded on average 758.22K shares per day over the past 3-months and 1.1M shares per day over the last 10 days, according to various share statistics. A total of 36.55M shares are outstanding, with a floating share count of 35.41M. Insiders hold about 2.93% of the company’s shares, while institutions hold 113.16% stake in the company. Shares short for CRI as of Feb 29, 2024 were 2.82M with a Short Ratio of 4.36, compared to 3.83M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.73% and a Short% of Float of 7.95%.
Dividends & Splits
In the trailing 12 months, CRI’s forward annual dividend rate was 3.00, compared to 3.05 this year. Against a Trailing Annual Dividend Yield of 3.65%, it implies a Forward Annual Dividend Yield of 3.67%. The stock’s 5-year Average Dividend Yield is 1.66. The current Payout Ratio is 48.10% for CRI, which recently paid a dividend on Mar 29, 2024 with an ex-dividend date of Mar 08, 2024. Stock splits for the company last occurred on Jun 07, 2006 when the company split stock in a 2:1 ratio.
Earnings Estimates
Its stock is currently analyzed by 6 different market analysts. On average, analysts expect EPS of $0.75 for the current quarter, with a high estimate of $0.98 and a low estimate of $0.6, while EPS last year was $0.98. The consensus estimate for the next quarter is $0.83, with high estimates of $1.01 and low estimates of $0.65.
Analysts are recommending an EPS of between $6.6 and $6 for the fiscal current year, implying an average EPS of $6.35. EPS for the following year is $6.66, with 7 analysts recommending between $7.09 and $5.95.
Revenue Estimates
6 analysts predict $639M in revenue for the current quarter. It ranges from a high estimate of $660.17M to a low estimate of $620.91M. As of the current estimate, Carters Inc’s year-ago sales were $648.58M, an estimated decrease of -1.50% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $618.38M, an increase of 3.10% over than the figure of -$1.50% in the same quarter last year. There is a high estimate of $638.34M for the next quarter, whereas the lowest estimate is $595.29M.
A total of 6 analysts have provided revenue estimates for CRI’s current fiscal year. The highest revenue estimate was $2.99B, while the lowest revenue estimate was $2.93B, resulting in an average revenue estimate of $2.96B. In the same quarter a year ago, actual revenue was $2.95B, up 0.60% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $3.02B in the next fiscal year. The high estimate is $3.07B and the low estimate is $2.93B. The average revenue growth estimate for next year is up 2.00% from the average revenue estimate for this year.
